Enjoy complimentary customisation on priority with our Enterprise License!
The ibuprofen active pharmaceutical ingredient (API) market is estimated to grow by USD 31.68 million at a CAGR of 2.53% between 2022 and 2027. The growth of the market depends on several factors, including the increasing geriatric population, the evolving API manufacturing scenario in developing countries, and the increase in pharmaceutical and biopharmaceutical production.
It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The increasing geriatric population is notably driving the market, although factors such as stringent regulations may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Driver
The increasing geriatric population is notably driving the market. The risk of contracting chronic illness increases with age, which, in turn, fuels the demand for ibuprofen APIs. According to the Centers for Disease Control and Prevention (CDC), the number of US adults aged 65 years and above is expected to reach approximately 71 million. This will increase the diagnosis of age-related diseases in the susceptible patient population, which will fuel the adoption of different therapeutics.
The growth in the geriatric population increases the burden on the national health system. As a result, healthcare financing has become a critical policy issue. Therefore, national healthcare regulatory bodies promote the use of generic drugs to reduce the impact of economic burden. This, in turn, increases the penetration of generic drug manufacturers in the US and Europe. Such manufacturers outsource raw materials from ibuprofen API manufacturers to provide cost-effective therapeutics. This, in turn, will contribute to the global market during the forecast period.
Significant Market Trend
The paradigm shift in API manufacturing is a key trend influencing the market. Many pharmaceutical companies outsource a large share of their research and manufacturing processes to drug manufacturing organizations. Outsourcing is done due to several factors, such as industry trends, the high cost of acquiring new technologies, and the availability of internal capacity.
Outsourcing the manufacturing of ibuprofen APIs is helpful for small organizations that do not have the internal capacity and financial budget to manufacture ibuprofen APIs in-house. It also saves time invested in manufacturing. Outsourcing of ibuprofen APIs enables innovators and manufacturers to meet development timelines while capitalizing on high efficiency in their supply chain. Therefore, the paradigm shift from captive ibuprofen API manufacturing to contract ibuprofen API manufacturing is anticipated to have a positive impact on market during the forecast period.
Major Market Challenge
Stringent regulations are challenging market. Regulatory authorities need to evaluate drug-related data carefully before approval. They examine aspects such as safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions. If a drug fails any of these criteria, the applicant may receive a complete response letter (CRL) or face complete rejection from regulatory agencies.
A drug applicant needs to furnish additional data about the drug after receiving a CRL, which may require additional clinical trials and increase the R&D expenditure of the drug. In some cases, drug applicants withdraw their applications and discontinue their drug trials. These factors are expected to hinder the global market during the forecast period.
Key Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Chemino Pharma Ltd. - The company is engaged in the manufacturing of pharmaceutical products such as active pharmaceutical ingredients, intermediate chemicals, and trading of solvents such as toluene, ISO propyl alcohol, phenol, and ethyl acetate. The key offerings of the company include nonsteroidal ibuprofen anti-inflammatory drugs.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the pharmaceutical companies segment will be significant during the forecast period. This is one of the most popular products in this segment owing to its wide range of applications, such as easing mild to moderate pain, including toothache, migraine, and menstrual cramps. It is used as an analgesic and antipyretic agent and has anti-inflammatory properties. This is also used in the treatment of various conditions, such as rheumatoid arthritis and osteoarthritis.
Get a glance at the market contribution of various segments Request a PDF Sample
The pharmaceutical companies segment was valued at USD 130.40 million in 2017 and continued to grow until 2021. Ibuprofen inhibits the production of prostaglandins, which are hormones that cause pain and inflammation. It is a popular choice for the treatment of pain, as it is relatively safe and effective. These factors will drive the growth of the segment during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
Asia is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The growth of the market is attributed to factors such as the growing prevalence of migraine, chronic disorders, and other disorders. The manufacturing of pharmaceutical drugs, such as ibuprofen API, is increasing in Asia due to low manufacturing costs in China and India. As a result, the number of production facilities has increased. The increasing geriatric population will also drive the growth of the market in Asia. The geriatric population is more prone to chronic diseases. Hence, the anticipated rise in population is expected to fuel the demand for innovative pain relief. These factors will drive the growth of the market in Asia during the forecast period.
The market research report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The Market is influenced by factors such as Basis Point Share (BPS), with a focus on sustainable manufacturing and environmentally restrictive impacts. The synthesis of Ibuprofen API involves adherence to production guidelines, raw material sourcing, and exploring advanced synthesis routes. This is a key component in pharmaceutical formulations, particularly in nonsteroidal anti-inflammatory drugs (NSAIDs). It is widely used for its analgesic, antipyretic, and anti-inflammatory actions, making it a popular choice for OTC sales.
In drug development, effective drug candidate identification is crucial. This involves the use of bioinformatics, high throughput screening, and combinatorial chemistry to discover potential candidates. Technological innovations in drug discovery, including high-throughput screening, multi-detector readers, automation, and imaging hardware and software, are driving growth in the market. End users, including contract manufacturing organisations (CMOs), play a significant role in the market. The market is expected to witness sales growth, especially in women's healthcare, due to its effective results in managing body pain, joint pain, and various inflammatory conditions such as ankylosing spondylitis, lupus, gout, psoriatic arthritis, and pseudogout. However, challenges such as labour costs, taxation, healthcare infrastructure, stress, pollution, and biological heredity may impact market dynamics. Additionally, the use of Ibuprofen API in patients with cardiovascular diseases, including patent ductus arteriosus in premature newborns, requires careful consideration of dosage and administration, either orally or intravenously, to avoid adverse effects.
Ibuprofen API Market Scope |
|
Report Coverage |
Details |
Page number |
151 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 2.53% |
Market growth 2023-2027 |
USD 31.68 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
1.76 |
Regional analysis |
Asia, North America, Europe, and Rest of World (ROW) |
Performing market contribution |
Asia at 42% |
Key countries |
US, Germany, UK, India, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt Ltd., Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Titan Lab Pvt Ltd., and Otto Brandes GmbH |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.